This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignees: Gilead Sciences, Inc., Nurix Therapeutics, Inc.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 946 
1 out of 22 Years Active: 2024
Title: Lan Wang - Innovator in Therapeutic Compounds
Introduction
Lan Wang is a prominent inventor based in San Francisco, CA. She has made significant contributions to the field of therapeutic compounds, particularly in the development of bifunctional degraders. Her innovative work has the potential to impact the treatment of various diseases.
Latest Patents
Lan Wang holds a patent for "Bifunctional degraders of hematopoietic progenitor kinase and therapeutic uses thereof." This patent provides a detailed disclosure of bifunctional compounds that act as HPK1 degraders through the ubiquitin proteasome pathway. The method outlined in her patent aims to treat diseases that are modulated by HPK1, showcasing her commitment to advancing medical science.
Career Highlights
Throughout her career, Lan Wang has worked with notable companies such as Gilead Sciences, Inc. and Nurix Therapeutics, Inc. Her experience in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of her coworkers include Mark Edward Zak and John Buell. Their collaborative efforts have further enhanced the research and development of innovative therapeutic solutions.
Conclusion
Lan Wang's contributions to the field of therapeutic compounds exemplify her dedication to innovation and medical advancement. Her work continues to inspire future research and development in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile